University of Edinburgh

In order to understand and track early disease progression the European Prevention of Alzheimer’s Dementia (EPAD) consortium, the largest public-private partnership in the history of AD research, established a European-wide Longitudinal Cohort Study (LCS) that screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data. Although the EPAD LCS closed in 2019 the bioresource remains which contains over 100,000 samples including, blood products, saliva, urine and Cerebral Spinal Fluid (CSF), all collected from EPAD participants, which can be used to further our understanding of neurodegenerative disease. EPAD consent signed by the participants covers sample storage for at least 15 years and use by local (The University of Edinburgh and other scientists for additional research in the future. Also, information that could be obtained from the analysis of EPAD samples may be used scientifically and may be used in other research.

Existing samples:

  • Alzheimer's disease (disorder)

Contact Information

Email:
natalia.matveyev@ed.ac.uk
Address:

Alexander Robertson Building
The Roslin Institute and R(D)SVS
Easter Bush Campus
Edinurgh
Midlothian
EH25 9RG
Scotland

Last Updated: 02/06/2021


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A